TATA Health International Holdings Ltd.(HK:1255)
HK$1.58-0.13 (-7.60%)
HK:1255
TATA Health International Holdings Ltd. financials statements
HK$1.58
At close:-0.13 (-7.60%)
Want to see HK:1255 full AI Analyst Report?
TATA Health International Holdings Ltd. (1255) Ratios
9 Followers
TATA Health International Holdings Ltd. Ratios
HK:1255's free cash flow for Q2 2026 was HK$-4.03M. For the 2026 fiscal year, HK:1255's free cash flow was decreased by HK$-1.73M and operating cash flow was HK$-2.29M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Jun 25 | Dec 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.50 | 0.75 | 0.61 | 0.67 | 0.75 |
| Quick Ratio | 0.43 | 0.68 | 0.55 | 0.53 | 0.61 |
| Cash Ratio | 0.13 | 0.22 | 0.13 | 0.23 | 0.18 |
| Solvency Ratio | 0.17 | -0.16 | -0.28 | 0.14 | -0.35 |
| Operating Cash Flow Ratio | -0.13 | 0.00 | 0.00 | 0.09 | -0.03 |
| Short-Term Operating Cash Flow Coverage | -1.81 | 0.00 | 0.00 | 0.42 | -0.16 |
| Net Current Asset Value | HK$ -74.41M | HK$ -61.47M | HK$ -79.21M | HK$ -57.05M | HK$ -51.70M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.28 | 0.30 | 0.27 | 0.29 | 0.30 |
| Debt-to-Equity Ratio | -0.48 | 31.62 | -0.56 | 1.52 | 2.29 |
| Debt-to-Capital Ratio | -0.91 | 0.97 | -1.26 | 0.60 | 0.70 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.34 |
| Financial Leverage Ratio | -1.67 | 105.82 | -2.10 | 5.23 | 7.69 |
| Debt Service Coverage Ratio | -0.94 | -1.24 | -2.06 | 0.53 | -1.59 |
| Interest Coverage Ratio | -8.29 | -19.94 | -12.91 | -12.05 | -20.69 |
| Debt to Market Cap | 0.03 | 0.34 | 0.21 | 0.14 | 0.11 |
| Interest Debt Per Share | 0.12 | 0.23 | 0.17 | 0.22 | 0.24 |
| Net Debt to EBITDA | -0.68 | -0.43 | -0.33 | 0.93 | -0.50 |
| Profitability Margins | |||||
| Gross Profit Margin | 80.43% | 72.64% | 68.26% | 78.80% | 65.07% |
| EBIT Margin | -23.24% | -16.56% | -44.08% | 4.56% | -41.25% |
| EBITDA Margin | -11.67% | -16.03% | -31.60% | 12.87% | -32.34% |
| Operating Profit Margin | -23.24% | -16.56% | -44.08% | -20.79% | -35.44% |
| Pretax Profit Margin | 14.02% | -17.07% | -54.66% | 2.84% | -42.97% |
| Net Profit Margin | 13.38% | -15.56% | -54.91% | 6.65% | -43.78% |
| Continuous Operations Profit Margin | 13.38% | -17.37% | -54.91% | 2.22% | -43.78% |
| Net Income Per EBT | 95.45% | 91.17% | 100.45% | 234.23% | 101.90% |
| EBT Per EBIT | -60.30% | 103.03% | 124.01% | -13.65% | 121.24% |
| Return on Assets (ROA) | 14.65% | -17.73% | -50.55% | 5.46% | -39.84% |
| Return on Equity (ROE) | -24.52% | -1876.47% | 106.03% | 28.57% | -306.19% |
| Return on Capital Employed (ROCE) | 45.53% | 5465.50% | 114.98% | -109.02% | -208.88% |
| Return on Invested Capital (ROIC) | 80.15% | -86.14% | 286.15% | -33.56% | -86.03% |
| Return on Tangible Assets | 14.65% | -17.73% | -50.55% | 4.35% | -39.84% |
| Earnings Yield | 4.23% | -42.22% | -93.80% | 4.50% | -19.10% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.02 | 23.57 | 27.39 | 5.86 | 9.96 |
| Payables Turnover | 5.30 | 12.18 | 9.94 | 3.23 | 17.61 |
| Inventory Turnover | 2.05 | 4.26 | 3.67 | 1.45 | 2.87 |
| Fixed Asset Turnover | 8.16 | 7.48 | 9.89 | 6.45 | 14.71 |
| Asset Turnover | 1.10 | 1.14 | 0.92 | 0.82 | 0.91 |
| Working Capital Turnover Ratio | -1.41 | -4.40 | -2.13 | -3.35 | -19.23 |
| Cash Conversion Cycle | 229.98 | 71.17 | 76.11 | 201.32 | 143.06 |
| Days of Sales Outstanding | 121.03 | 15.48 | 13.33 | 62.34 | 36.65 |
| Days of Inventory Outstanding | 177.88 | 85.65 | 99.51 | 252.09 | 127.14 |
| Days of Payables Outstanding | 68.93 | 29.96 | 36.72 | 113.11 | 20.73 |
| Operating Cycle | 298.91 | 101.13 | 112.84 | 314.43 | 163.79 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.08 | 0.00 | 0.00 | 0.05 | -0.02 |
| Free Cash Flow Per Share | -0.09 | 0.00 | 0.00 | 0.05 | -0.03 |
| Dividend Paid and CapEx Coverage Ratio | -4.88 | 0.00 | 0.00 | 14.68 | -4.54 |
| Capital Expenditure Coverage Ratio | -4.88 | 0.00 | 0.00 | 14.68 | -4.54 |
| Operating Cash Flow Coverage Ratio | -0.72 | 0.00 | 0.00 | 0.25 | -0.09 |
| Operating Cash Flow to Sales Ratio | -0.19 | 0.00 | 0.00 | 0.09 | -0.03 |
| Free Cash Flow Yield | -7.09% | 0.00% | 0.00% | 5.67% | -1.62% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 23.64 | -2.37 | -1.07 | 22.23 | -5.24 |
| Price-to-Sales (P/S) Ratio | 3.16 | 0.37 | 0.59 | 1.48 | 2.29 |
| Price-to-Book (P/B) Ratio | -5.80 | 44.45 | -1.13 | 6.35 | 16.03 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -14.09 | 0.00 | 0.00 | 17.63 | -61.74 |
| Price-to-Operating Cash Flow Ratio | -16.98 | 0.00 | 0.00 | 16.43 | -75.35 |
| Price-to-Earnings Growth (PEG) Ratio | -0.20 | 0.01 | -0.01 | -0.20 | 0.08 |
| Enterprise Value Multiple | -27.80 | -2.73 | -2.18 | 12.41 | -7.59 |
| Enterprise Value | 323.65M | 90.91M | 85.76M | 231.09M | 394.85M |
| EV to EBITDA | -27.80 | -2.73 | -2.18 | 12.41 | -7.59 |
| EV to Sales | 3.24 | 0.44 | 0.69 | 1.60 | 2.45 |
| EV to Free Cash Flow | -14.45 | 0.00 | 0.00 | 19.07 | -66.08 |
| EV to Operating Cash Flow | -17.41 | 0.00 | 0.00 | 17.77 | -80.65 |
| Tangible Book Value Per Share | -0.22 | -0.07 | -0.23 | 0.08 | 0.06 |
| Shareholders’ Equity Per Share | -0.22 | 0.01 | -0.27 | 0.14 | 0.10 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.05 | -0.02 | -0.00 | 0.22 | -0.02 |
| Revenue Per Share | 0.41 | 0.85 | 0.51 | 0.60 | 0.69 |
| Net Income Per Share | 0.05 | -0.13 | -0.28 | 0.04 | -0.30 |
| Tax Burden | 0.95 | 0.91 | 1.00 | 2.34 | 1.02 |
| Interest Burden | -0.60 | 1.03 | 1.24 | 0.62 | 1.04 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 1.04 | 0.48 | 1.12 | 0.57 | 0.60 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -1.39 | 0.00 | 0.00 | 3.17 | 0.07 |
Currency in HKD

